162 related articles for article (PubMed ID: 31878037)
21. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
Troiano G; Guida A; Aquino G; Botti G; Losito NS; Papagerakis S; Pedicillo MC; Ionna F; Longo F; Cantile M; Pennella A; Lo Russo L; Di Gioia G; Mariggiò MA; Lo Muzio L; Pannone G
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205554
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity.
Zhou X; Zhang Z; Yang X; Chen W; Zhang P
Int J Cancer; 2009 Jan; 124(2):483-9. PubMed ID: 18942709
[TBL] [Abstract][Full Text] [Related]
23. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan.
Kuo MY; Lin CY; Hahn LJ; Cheng SJ; Chiang CP
J Oral Pathol Med; 1999 Apr; 28(4):165-9. PubMed ID: 10235369
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
25. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of neural stem cell markers, Nestin and Musashi-1, in oral squamous cell carcinoma: expression pattern of Nestin in the precancerous stages of oral squamous epithelium.
Ravindran G; Devaraj H
Clin Oral Investig; 2015 Jul; 19(6):1251-60. PubMed ID: 25352468
[TBL] [Abstract][Full Text] [Related]
27. Correlation of cyclin D1 expression with aggressive DNA pattern in patients with tobacco-related intraoral squamous cell carcinoma.
Das SN; Khare P; Singh MK; Sharma SC
Indian J Med Res; 2011 Apr; 133(4):381-6. PubMed ID: 21537090
[TBL] [Abstract][Full Text] [Related]
28. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma.
Wu CC; Xiao Y; Li H; Mao L; Deng WW; Yu GT; Zhang WF; Sun ZJ
Pathol Res Pract; 2019 Apr; 215(4):772-778. PubMed ID: 30683473
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
32. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
[TBL] [Abstract][Full Text] [Related]
33. Expression of cyclin D1 correlates with p27
Guan G; Bakr MM; Firth N; Love RM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Aug; 126(2):174-183. PubMed ID: 29550080
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the Musashi-2 (MSI2) gene in childhood acute lymphoblastic leukemia.
Zhao HZ; Jia M; Luo ZB; Cheng YP; Xu XJ; Zhang JY; Li SS; Tang YM
Neoplasma; 2016; 63(1):150-7. PubMed ID: 26639245
[TBL] [Abstract][Full Text] [Related]
35. [Expression and its significance of Cyclin D1 in oral squamous cell carcinoma].
Xing JS; Shi PR; Chen XJ; He DN; Li LH; Nan XR
Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Jun; 29(3):299-301, 305. PubMed ID: 21776860
[TBL] [Abstract][Full Text] [Related]
36. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
[TBL] [Abstract][Full Text] [Related]
37. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Zhu Q; Tian G; Gao J
Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
[TBL] [Abstract][Full Text] [Related]
38. An immunohistochemical score to predict the outcome for oral squamous cell carcinoma.
Monteiro LS; Diniz-Freitas M; Warnakulasuriya S; Garcia-Caballero T; Forteza J; Fraga M
J Oral Pathol Med; 2018 Apr; 47(4):375-381. PubMed ID: 29344992
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression.
Lam KY; Ng IO; Yuen AP; Kwong DL; Wei W
J Oral Pathol Med; 2000 Apr; 29(4):167-72. PubMed ID: 10766394
[TBL] [Abstract][Full Text] [Related]
40. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
